UBS Maintains Neutral on Viavi Solutions, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 57.2%

Neg 0% Neu 0% Pos 57.2%

UBS analyst Andrew Spinola maintains Viavi Solutions (NASDAQ:VIAV) with a Neutral and raises the price target from $25 to $60.